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Resistance in Infected Cattle in Aydın Region 
 
Tropical theileriosis is a protozoal disease caused by Theileria annulata leading to 
serious economic losses due to high morbidity and mortality. Buparvaquone is the only drug 
currently used to treat cases of tropical theileriosis in the field. However, an increase in the 
rate of treatment failure cases of tropical theileriosis has been observed in recent years, raising 
the possibility of resistance developed against buparvaquone. according to this hypothesis, the 
present study aim to investigate the mutations in Theileria annulata cytochrome b gene in 
association with buparvaquone resistance and the detection of prevalence of buparvaquone 
resistance in infected cattle in Aydın region. To this end, susceptibility to buparvaquone was 
examined by comparing the proliferative index of infected cells, which were obtained from 
cattle with theileriosis before and/or after treatment, under titration of buparvaquone dose 
using the MTT assay. Cell lines identified as resistant or susceptible were then genotyped 
using satellite markers and the DNA sequence of the T. annulata cytochrome b gene 
determined. The results identified six nonsynonymous and six synonymous mutations. Two 
out of six nonsynonymous mutations were found to be located at putative buparvaquone 
binding regions of cytochrome b. These mutations result in amino acid substitutions from 
valine 135 to alanine or proline 253 to serine. Isolates possessing an identified mutation were 
cloned and tested with the MTT assay which indicated that the clones with either of the two 
mutations located in the binding regions are resistant to buparvaquone. To test for the 
frequency of these mutations in the field, an allele specific PCR was developed. The results 
demonstrated that the mutation V135A in 10 out of 168 T. annulata positive blood samples 
and two out of 127 T. annulata macroschizont infected cell lines, while the P253S mutation 
was detected in one out of 168 T. annulata positive blood samples and eight out of 127 cell 
lines. These data suggest that the two point mutations are candidates for generation of genetic 
resistance of T. annulata against buparvaquone. 
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